RICERCA CLINICA OPERATA CON UN NUOVA FARMACO NEL TRATTAMENTO DI PAZIENTI CON VASCULOPATIA CEREBRALE

Translated title of the contribution: 'Clinical trial with a new substance active in the treatment of patients with vascular brain disorders'

Research output: Contribution to journalArticlepeer-review

Abstract

Suloctidil, a new vasodilator agent which also stimulates brain energy metabolism, was administered to 26 patients with cerebral vascular disorders. The treatment period, with capsules containing mg 200 of suloctidil, was always 14 days. The therapy induced a good reduction of clinical and psychic symptoms, of high blood pressure values and of some laboratory tests (Breddin test, blood cholesterol).

Translated title of the contribution'Clinical trial with a new substance active in the treatment of patients with vascular brain disorders'
Original languageItalian
Pages (from-to)277-281
Number of pages5
JournalGiornale di Gerontologia
Volume28
Issue number4
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of ''Clinical trial with a new substance active in the treatment of patients with vascular brain disorders''. Together they form a unique fingerprint.

Cite this